Skip to main content

Table 1 Patient characteristics

From: High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients

Variables Total number (%)
Gender
 Male 100 (72.5)
 Female 38 (27.5)
Age, years [median (IQR)] 60 (53–69)
Site
 Low 43 (31.2)
 Middle 75 (54.3)
 High 20 (14.5)
Tumor size
  > 5 cm 63 (45.7)
  ≤ 5 cm 75 (54.3)
cTNM
 II 31 (22.5)
 III 107 (77.5)
ypTNM
 0-I 74 (53.6)
 II-III 64 (46.4)
Histopathology
 Well differentiation 6 (4.7)
 Moderate differentiation 109 (84.5)
 Poor differentiation 14 (10.9)
LVI
 Positive 8 (5.8)
 Negative 130 (94.2)
PNI
 Positve 17 (12.3)
 Negative 121 (87.7)
Tumor deposits
 Positive 20 (14.5)
 Negative 118 (85.5)
TRG
 0–1 80 (58.0)
 2–3 58 (42.0)
LNH [median (IQR)] 8.8 (5.0–12.0)
CEA [median (IQR)] 3.5 (1.8–4.1)
FARI% [median (IQR)] 7.7 (6.5–8.7)
PNI [median (IQR)] 45.9 (43.2–48.5)
CFP
 Low 95 (68.8)
 High 43 (31.2)
  1. IQR interquartile rangel, LVI lymphovascular invasion, PNI perineural invasion, TRG tumor regression grade, LHN lymph node harvest, CEA carcinoembryonic antigen, PNI prognostic nutrition index, FARI fibrinogen–Albumin Ratio Index, CFP CEA-FARI-PNI score